Sputum microRNA biomarkers for identifying lung cancer in indeterminate solitary pulmonary nodules

Clinical Cancer Research

Volumn 21, Issue 2, 2015, Pages 484-489

  Xing, Lingxiao ^a   Su, Jian ^b   Guarnera, Maria A ^b   Zhang, Howard ^b   Cai, Ling ^b   Zhou, Rixin ^c   Stass, Sanford A ^b   Jiang, Feng ^b  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c Nevada Cancer Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 21; MICRORNA 210; MICRORNA 31; TUMOR MARKER;

AGED; ARTICLE; CANCER SCREENING; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; GENE EXPRESSION; GENETIC SCREENING; HUMAN; LUNG CANCER; LUNG NODULE; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; PROCESS DEVELOPMENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SMOKING; SPUTUM ANALYSIS; SPUTUM CYTODIAGNOSIS; GENETICS; LUNG NEOPLASMS; METABOLISM; MIDDLE AGED; RECEIVER OPERATING CHARACTERISTIC; SOLITARY PULMONARY NODULE; SPUTUM;

AGED; BIOMARKERS, TUMOR; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; ROC CURVE; SOLITARY PULMONARY NODULE; SPUTUM;

EID: 84920973525     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-14-1873     Document Type: Article

References (27)

1. Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395-409.
2. Patz EF Jr, Pinsky P, Gatsonis C, Sicks JD, Kramer BS, TammemagiMC, et al. Overdiagnosis in low-dose computed tomography screening for lung cancer. JAMA Intern Med 2014;174:269-74.
3. MacMahon H, Austin JH, Gamsu G, Herold CJ, Jett JR, Naidich DP, et al. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology 2005;237: 395-400.
4. Saccomanno G, Saunders RP, Archer VE, Auerbach O, Kuschner M, Beckler PA. Cancer of the lung: the cytology of sputum prior to the development of carcinoma. Acta Cytol 1965;9:413-23.
5. Hubers AJ, Prinsen CF, Sozzi G, Witte BI, Thunnissen E. Molecular sputum analysis for the diagnosis of lung cancer. Br J Cancer 2013;6:530-7.
6. Qiu Q, Todd NW, Li R, Peng H, Liu Z, Yfantis HG, et al. Magnetic enrichment of bronchial epithelial cells from sputum for lung cancer diagnosis. Cancer 2008;114:275-83.
7. Croce CM, Calin GA. miRNAs, cancer, and stem cell division. Cell 2005;122:6-7.
8. Visone R, Croce CM. MiRNAs and cancer. Am J Pathol 2009;174:1131-8.
9. Xie Y, Todd NW, Liu Z, Zhan M, Fang H, Peng H, et al. Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer. Lung Cancer 2010;67:170-6.
10. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 2008;105:10513-8.
11. Xing L, Todd NW, Yu L, Fang H, Jiang F. Early detection of squamous cell lung cancer in sputum by a panel of microRNA markers. Mod Pathol 2010;23:1157-64.
12. Yu L, Todd NW, Xing L, Xie Y, Zhang H, Liu Z, et al. Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers. Int J Cancer 2010;127:2870-8.
13. Shen J, Liao J, Guarnera MA, Fang H, Cai L, Stass SA, et al. Analysis of MicroRNAs in sputum to improve computed tomography for lung cancer diagnosis. J Thorac Oncol 2014;9:33-40.
14. Roa WH, Kim JO, Razzak R, Du H, Guo L, Singh R, et al. Sputum microRNA profiling: a novel approach for the early detection of non-small cell lung cancer. Clin Invest Med 2012;35:271.
15. Romeo MS, Sokolova IA, Morrison LE, Zeng C, Baron AE, Hirsch FR, et al. Chromosomal abnormalities in non-small cell lung carcinomas and in bronchial epithelia of high-risk smokers detected by multi-target interphase fluorescence in situ hybridization. J Mol Diagn 2003;5:103-12.
16. Varella-Garcia M, Kittelson J, Schulte AP, Vu KO, Wolf HJ, Zeng C, et al. Multi-target interphase fluorescence in situ hybridization assay increases sensitivity of sputum cytology as a predictor of lung cancer. Cancer Detect Prev 2004;28:244-51.
17. Yu L, Shen J, Mannoor K, GuarneraM, Jiang F. Identification of ENO1 As a potential sputum biomarker for early-stage lung cancer by shotgun proteomics. Clin Lung Cancer 2014;14:110-7.
18. Li N, Ma J, Guarnera MA, Fang H, Cai L, Jiang F. Digital PCR quantification of miRNAs in sputum for diagnosis of lung cancer. J Cancer Res Clin Oncol 2014;140:145-50.
19. Anjuman N, Li N, Guarnera M, Stass SA, Jiang F. Evaluation of lung flute in sputum samples for molecular analysis of lung cancer. Clin Transl Med 2013;2:15-20.
20. Jiang F, ToddNW, Li R, Zhang H, Fang H, Stass SA. Apanel of sputum-based genomic marker for early detection of lung cancer. Cancer Prev Res 2010;3:1571-8.
21. Jiang F, Todd NW, Qiu Q, Liu Z, Katz RL, Stass SA. Combined genetic analysis of sputum and computed tomography for noninvasive diagnosis of non-small-cell lung cancer. Lung Cancer 2009;66:58-63.
22. Katz RL, Zaidi TM, Fernandez RL, Zhang J, He W, Acosta C, et al. Automated detection of genetic abnormalities combined with cytology in sputum is a sensitive predictor of lung cancer. Mod Pathol 2008;21:950-60.
23. Li R, Todd NW, Qiu Q, Fan T, Zhao RY, RodgersWH, et al. Genetic deletions in sputum as diagnostic markers for early detection of stage I non-small cell lung cancer. Clin Cancer Res 2007;13:482-7.
24. Machida EO, Brock MV, Hooker CM, Nakayama J, Ishida A, Amano J, et al. Hypermethylation of ASC/TMS1 is a sputum marker for late-stage lung cancer. Cancer Res 2006;66:6210-8.
25. Belinsky SA, Liechty KC, Gentry FD, Wolf HJ, Rogers J, Vu K, et al. Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort. Cancer Res 2006;66:3338-44.
26. Hennessey PT, Sanford T, Choudhary A, Mydlarz WW, Brown D, Adai AT, et al. Serum microRNA biomarkers for detection of non-small cell lung cancer. PLoS ONE 2012;7:32307.
27. Ma J, Mannoor K, Gao L, Tan A, Guarnera MA, Zhan M, et al. Characterization ofmicroRNA transcriptome in lung cancer by next-generation deep sequencing. Mol Oncol 2014;8:1208-19.